daunorubicin has been researched along with Hyperlipidemias in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kumagai, A; Matsuoka, N; Mizobuchi, M; Morisaki, N; Saito, Y; Shinomiya, M | 1 |
| Irikura, T; Itaroku, K; Mochizuki, T; Okada, K; Takagi, K | 1 |
2 other study(ies) available for daunorubicin and Hyperlipidemias
| Article | Year |
|---|---|
Lipid metabolism in the aorta of daunomycin-induced nephrotic rats.
Topics: Animals; Aorta; Arteriosclerosis; Cholesterol; Daunorubicin; Hyperlipidemias; Lipoproteins; Male; Nephrosis; Rats; Rats, Inbred Strains | 1983 |
[Experimental nephrotic hyperlipidemia induced in rats by daunorubicin and effects of KCD-232[4-(4'-chlorobenzyloxy)benzyl nicotinate] on lipid metabolism].
Topics: Adipose Tissue; Animals; Daunorubicin; Hyperlipidemias; Hypolipidemic Agents; Intestinal Absorption; Lipid Metabolism; Liver; Male; Nephrosis; Nicotinic Acids; Rats; Rats, Inbred Strains | 1985 |